National University Heart Centre.
Evidence-Based Nursing Unit, National University Hospital.
JBI Evid Implement. 2021 Mar;19(1):94-104. doi: 10.1097/XEB.0000000000000242.
Subcutaneous delivery of anticoagulant therapy is a common treatment modality across multiple medical disciplines. However, postinjection complications of bruising and pain continues to be a problem that has the propensity to affect patients physically and psychologically. A review of literature revealed a set of recommended injection techniques that have shown to improve these clinical outcomes.
The project aims to utilize an evidence implementation framework to introduce evidence-based injection technique, for the reduction of postinjection complications.
A best practice implementation project was administered across three adult- cardiology and cardio-thoracic general wards in Singapore from March 2018 to February 2019. The Joanna Briggs Institute (JBI)'s framework of evidence implementation was utilized to enable change. A baseline audit was carried out to ascertain existing injection practices. Guided by the latest evidence, a new subcutaneous injection workflow was created and disseminated. Follow-up audits were held at 1 and 8-month postimplementation to assess compliance to the new subcutaneous injection workflow and the sustainment of change. Data were consolidated and analysed with the aid of JBI Practical Application of Clinical Evidence System. Barriers to change were also identified and addressed with the aid of JBI's Getting Research into Practice tool.
A large variation of subcutaneous injection techniques was observed at the baseline audit. At 1-month postimplementation, overall compliance with the new subcutaneous injection workflow was assessed to be 73.3%. Criteria 2 and 3 of the JBI Practical Application of Clinical Evidence System audit criteria improved from the baseline values (9.1-80%; 0-93.3%). At 8-month postimplementation, compliance rate remained high (83%) following strategies to reinforce and sustain change. Participants complied to Criteria 1 at all stages of the project. Correspondingly, the incidence of bruising reduced from baseline, with a relative risk reduction of 52% (1 month) and 29% (8 months). Median pain also decreased from the baseline, with an improvement from 2.0 (1.0-3.0) to 0.0 (0.0-1.0).
Introduction and sustainment of change requires careful planning and execution. JBI's framework of evidence implementation is an effective model to guide this process. This project also highlighted the value of continuous learning, clinical update and practice standardization. This is especially important in the current climate of nursing mobility worldwide and the associated practice variations based on nursing education and experience.
在多个医学学科中,皮下给予抗凝治疗是一种常见的治疗方式。然而,注射后瘀伤和疼痛等并发症仍然是一个问题,有可能对患者的身体和心理造成影响。文献回顾显示了一系列推荐的注射技术,这些技术已被证明可以改善这些临床结果。
本项目旨在利用证据实施框架引入基于证据的注射技术,以减少注射后并发症。
2018 年 3 月至 2019 年 2 月,在新加坡的三个成人心脏病学和心胸普通病房进行了一项最佳实践实施项目。利用乔安娜·布里格斯研究所(JBI)的证据实施框架来实现变革。进行了基线审核以确定现有的注射实践。在最新证据的指导下,创建并传播了新的皮下注射工作流程。在实施后 1 个月和 8 个月进行后续审核,以评估对新的皮下注射工作流程的遵守情况以及变更的维持情况。借助 JBI 实用临床证据系统整合和分析数据。还借助 JBI 的将研究转化为实践工具确定并解决了变革的障碍。
基线审核中观察到皮下注射技术存在很大差异。在实施后 1 个月,总体上评估新的皮下注射工作流程的依从率为 73.3%。JBI 实用临床证据系统审核标准的标准 2 和标准 3 从基线值提高(9.1-80%;0-93.3%)。在实施后 8 个月,通过加强和维持变更的策略,保持了较高的依从率(83%)。项目的所有阶段,参与者都遵守了标准 1。相应地,瘀伤的发生率从基线开始降低,相对风险降低了 52%(1 个月)和 29%(8 个月)。中位数疼痛也从基线开始下降,从 2.0(1.0-3.0)改善至 0.0(0.0-1.0)。
引入和维持变更需要仔细的计划和执行。JBI 的证据实施框架是指导这一过程的有效模式。该项目还强调了持续学习、临床更新和实践标准化的价值。在当前全球护理人员流动的背景下,以及基于护理教育和经验的相关实践差异,这一点尤其重要。